Intervention group: Allogeneic natural killer cell therapy.

2 trials

Sponsors

Shahid Beheshti University of Medical Sciences

Conditions

Acute myeloid leukemia. Acute myeloblastic leukaemiaMultiple myeloma. Multiple myeloma

Phase 2

Allogeneic natural killer cell therapy in multiple myeloma patients

RecruitingIRCT20230801058996N1

Shahid Beheshti University of Medical SciencesMultiple myeloma. Multiple myeloma

Start: 2023-01-22Target: 15Updated: 2023-10-16

Natural killer cell therapy in acute myeloid leukemia patients patients

RecruitingIRCT20230801058996N2

Shahid Beheshti University of Medical SciencesAcute myeloid leukemia. Acute myeloblastic leukaemia

Start: 2023-08-22Target: 15Updated: 2023-10-16

Related Papers

Natural Killer Cell Immunotherapy After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia Patients: Phase I Clinical Trial.

2026-08-03